News
7d
The Healthy @Reader's Digest on MSNNearly 640,000 Blood Sugar Devices Have Been Recalled at the Nation’s Highest Risk LevelIt's an evolved (and less prickly way) to monitor blood glucose, but a well known brand's defect could result in serious ...
Allspring Global Investments Holdings LLC grew its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 558.3% during the ...
The Dexcom G6 mobile app is designed to allow people to see glucose trends for the past 1, 3, 6, and 12 hours. But to review more comprehensive data, people can use the Dexcom CLARITY platform.
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been given an average rating of “Moderate Buy” by the twenty-two ratings firms that are covering the stock, MarketBeat.com reports. Four research ...
Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), is pleased to announce that coverage for Dexcom G6 ...
Dexcom G6 is now at its most accessible point ever under the NIHB program, making the highest degree of diabetes management possible for First Nations and Inuit peoples.
Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...
Dexcom, a global leader in real time continuous glucose monitoring for people with diabetes, is releasing the Dexcom G6 mobile app in Spanish, available immediately for users with a compatible iOS ...
The Dexcom G6 Pro gave me insights into how my body was behaving moment to moment, and how I can take charge and control how I feel. For me, this was a kind of academic fascination.
21d
Zacks Investment Research on MSNHere's Why You Should Retain PODD Stock in Your Portfolio NowInsulet Corporation’s PODD rapid commercial expansion of its Omnipod platform is poised to help it grow in the upcoming quarters. The rising adoption of Omnipod 5 also presents a promising growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results